Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Kura Oncology (KURA) and Amgen (AMGN)
TipRanksMay 3 11:34 ET
Express News | Wedbush Reiterates Outperform on Kura Oncology, Maintains $37 Price Target
BenzingaMay 3 09:42 ET
Scotiabank Keeps Their Hold Rating on Kura Oncology (KURA)
TipRanksMay 3 07:43 ET
Barclays Remains a Buy on Kura Oncology (KURA)
TipRanksMay 3 06:42 ET
Buy Rating Affirmed for Kura Oncology Amid Strong Financials and Promising Clinical Milestones
TipRanksMay 3 06:28 ET
Kura Oncology Inc (KURA) (Q1 2024) Earnings Call Transcript Highlights: Key Financial and ...
Yahoo FinanceMay 3 04:03 ET
ARDX, TNDM and VIAV Are Among After Hour Movers
Seeking AlphaMay 2 17:18 ET
Express News | Kura Oncology Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 GAAP EPS Results
BenzingaMay 2 17:11 ET
Express News | Kura Oncology Inc: Qtrly Shr Loss $0.59
ReutersMay 2 16:58 ET
Express News | Kura Oncology Inc: $527 Mln in Cash, Cash Equivalents and Investments Provide Runway Into 2027
ReutersMay 2 16:58 ET
Express News | Kura Oncology Q1 2024 GAAP EPS $(0.59) Misses $(0.55) Estimate
BenzingaMay 2 16:19 ET
Express News | Kura Oncology Q1 Operating Expenses USD 54.452 Million
ReutersMay 2 16:05 ET
Kura Oncology 1Q Loss/Shr 59c >KURA
Kura Oncology 1Q Loss/Shr 59c >KURA
Dow JonesMay 2 16:05 ET
Sector Update: Health Care Stocks Advance Premarket Monday
Health care stocks were advancing premarket Monday as the Health Care Select Sector SPDR Fund (XLV) was up 0.5% and the iShares Biotechnology ETF (IBB) was 0.8% higher recently. Vaxxinity (VAXX) was r
MT NewswiresApr 22 09:11 ET
Kura Oncology Says Potential Leukemia Drug Ziftomenib Gets FDA Breakthrough Therapy Designation
Kura Oncology (KURA) said Monday the US Food and Drug Administration has granted Breakthrough Therapy Designation for its potential leukemia drug ziftomenib.
MT NewswiresApr 22 08:17 ET
Kura Oncology Gets Breakthrough Designation For Leukemia Therapy
Kura Oncology said Monday it received a breakthrough therapy designation from regulators for ziftomenib, its potential treatment for a form of leukemia.
WSJApr 22 08:13 ET
Express News | Kura Oncology Shares Are Trading Higher After the Company Received FDA Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML
Moomoo 24/7Apr 22 07:39 ET
Kura Oncology's Ziftomenib, Has Been Granted FDA Breakthrough Therapy Designation For Relapsed/Refractory NPM1-mutant Acute Myeloid Leukemia
Kura Oncology's Ziftomenib, Has Been Granted FDA Breakthrough Therapy Designation For Relapsed/Refractory NPM1-mutant Acute Myeloid Leukemia
BenzingaApr 22 07:32 ET
Express News | Kura Oncology Inc - Registration-Directed Trial of Ziftomenib in Npm1-Mutant Aml on Track to Complete Enrollment by Mid-2024
Moomoo 24/7Apr 22 07:30 ET
Express News | Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in Npm1-Mutant Aml
Moomoo 24/7Apr 22 07:30 ET
No Data
No Data